WuXi Biologics Wins Five Asia-Pacific Biopharma Excellence Awards
- Written by PR Newswire
SHANGHAI, April 14, 2025 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced that it has received five awards at the 2025 Asia-Pacific Biopharma Excellence Awards (ABEA) ceremony. This also marks the seventh time that the company has been...
Read more: WuXi Biologics Wins Five Asia-Pacific Biopharma Excellence Awards














